The Europe Recombinant Proteins Market would witness market growth of 10.4% CAGR during the forecast period (2022-2028).
To boost research output and expand their product offerings for income creation, major firms are investing in their R&D initiatives. For instance, in 2021, Merck KGaA expended USD 2.44 billion (EUR 2.4 billion) on research and development, with the majority of the budget going toward healthcare and life sciences.
Such cases are anticipated to strengthen the argument for the expansion of R&D efforts and show the companies' commitment to making a difference for patients. Such corporate activities will probably support industry expansion in the upcoming years. Cloning antibody gene libraries into phage vectors and enabling the phages to infect a host cell line are both steps in the manufacture of recombinant antibodies.
Recombinant antibody development for COVID-19 infection is another area of business involvement. For instance, Sanofi and GSK began a new phase 2b trial with 720 volunteers who were 18 years of age or older in February 2021 to determine the best antigen dosage for the adjuvanted recombinant protein COVID-19 vaccine candidate's phase 3 evaluation.
The Department of Health has been the central government agency primarily in charge of establishing policies for the English healthcare and social care systems. The particular roles & responsibilities of the Department have changed as a result of the 2012 Health and Social Care Act, moving away from direct obligation for delivering the NHS to one that now offers strategic direction, serves as caretaker for the health and care system, evolves national policies, and offer guidance.
The Germany market dominated the Europe Recombinant Proteins Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $170.7 million by 2028. The UK market is anticipated to grow at a CAGR of 9.5% during (2022 - 2028). Additionally, The France market would exhibit a CAGR of 11.2% during (2022 - 2028).
Based on Product, the market is segmented into Growth Factors & Chemokines, Recombinant Metabolic Enzymes, Adhesion Molecules & Receptors, Structural Proteins, Membrane Proteins, Kinase Proteins & Regulatory Proteins, Immune Response Proteins, and Others. Based on End User, the market is segmented into Pharmaceutical & Biopharmaceutical Companies, Biotechnology Companies, Academic Research Institutes, Contract Research Organizations, and Others. Based on Application, the market is segmented into Drug Discovery & Development, Academic Research Studies, Biopharmaceutical Production, Diagnostics, Biotechnology Research, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Global Recombinant Proteins Market will Hit $2.6 Billion by 2028, at a CAGR of 10.8%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Bio-Techne Corporation, Thermo Fisher Scientific, Inc., Merck Group, Bio-Rad Laboratories, Inc., Abcam plc, Genscript Biotech Corporation, Miltenyi Biotec B.V. & Co. KG, Proteintech Group, Inc., BPS Bioscience, Inc., and RayBiotech Life, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Product
- Growth Factors & Chemokines
- Recombinant Metabolic Enzymes, Adhesion Molecules & Receptors
- Structural Proteins
- Membrane Proteins
- Kinase Proteins & Regulatory Proteins
- Immune Response Proteins
- Others
By End User
- Pharmaceutical & Biopharmaceutical Companies
- Biotechnology Companies
- Academic Research Institutes
- Contract Research Organizations
- Others
By Application
- Drug Discovery & Development
- Academic Research Studies
- Biopharmaceutical Production
- Diagnostics
- Biotechnology Research
- Others
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Key Market Players
List of Companies Profiled in the Report:
- Bio-Techne Corporation
- Thermo Fisher Scientific, Inc.
- Merck Group
- Bio-Rad Laboratories, Inc.
- Abcam plc
- Genscript Biotech Corporation
- Miltenyi Biotec B.V. & Co. KG
- Proteintech Group, Inc.
- BPS Bioscience, Inc.
- RayBiotech Life, Inc.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Recombinant Proteins Market, by Product
1.4.2 Europe Recombinant Proteins Market, by End User
1.4.3 Europe Recombinant Proteins Market, by Application
1.4.4 Europe Recombinant Proteins Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies Deployed in Recombinant Proteins Market
Chapter 4. Europe Recombinant Proteins Market by Product
4.1 Europe Growth Factors & Chemokines Market by Country
4.2 Europe Recombinant Metabolic Enzymes, Adhesion Molecules & Receptors Market by Country
4.3 Europe Structural Proteins Market by Country
4.4 Europe Membrane Proteins Market by Country
4.5 Europe Kinase Proteins & Regulatory Proteins Market by Country
4.6 Europe Immune Response Proteins Market by Country
4.7 Europe Others Market by Country
Chapter 5. Europe Recombinant Proteins Market by End User
5.1 Europe Pharmaceutical & Biopharmaceutical Companies Market by Country
5.2 Europe Biotechnology Companies Market by Country
5.3 Europe Academic Research Institutes Market by Country
5.4 Europe Contract Research Organizations Market by Country
5.5 Europe Others Market by Country
Chapter 6. Europe Recombinant Proteins Market by Application
6.1 Europe Drug Discovery & Development Market by Country
6.2 Europe Academic Research Studies Market by Country
6.3 Europe Biopharmaceutical Production Market by Country
6.4 Europe Diagnostics Market by Country
6.5 Europe Biotechnology Research Market by Country
6.6 Europe Others Market by Country
Chapter 7. Europe Recombinant Proteins Market by Country
7.1 Germany Recombinant Proteins Market
7.1.1 Germany Recombinant Proteins Market by Product
7.1.2 Germany Recombinant Proteins Market by End User
7.1.3 Germany Recombinant Proteins Market by Application
7.2 UK Recombinant Proteins Market
7.2.1 UK Recombinant Proteins Market by Product
7.2.2 UK Recombinant Proteins Market by End User
7.2.3 UK Recombinant Proteins Market by Application
7.3 France Recombinant Proteins Market
7.3.1 France Recombinant Proteins Market by Product
7.3.2 France Recombinant Proteins Market by End User
7.3.3 France Recombinant Proteins Market by Application
7.4 Russia Recombinant Proteins Market
7.4.1 Russia Recombinant Proteins Market by Product
7.4.2 Russia Recombinant Proteins Market by End User
7.4.3 Russia Recombinant Proteins Market by Application
7.5 Spain Recombinant Proteins Market
7.5.1 Spain Recombinant Proteins Market by Product
7.5.2 Spain Recombinant Proteins Market by End User
7.5.3 Spain Recombinant Proteins Market by Application
7.6 Italy Recombinant Proteins Market
7.6.1 Italy Recombinant Proteins Market by Product
7.6.2 Italy Recombinant Proteins Market by End User
7.6.3 Italy Recombinant Proteins Market by Application
7.7 Rest of Europe Recombinant Proteins Market
7.7.1 Rest of Europe Recombinant Proteins Market by Product
7.7.2 Rest of Europe Recombinant Proteins Market by End User
7.7.3 Rest of Europe Recombinant Proteins Market by Application
Chapter 8. Company Profiles
8.1 Bio-Techne Corporation
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.5.2 Product Launches and Product Expansions:
8.2 Thermo Fisher Scientific, Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Acquisition and Mergers:
8.3 Merck Group
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.4 Bio-Rad laboratories, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 Recent strategies and developments:
8.4.5.1 Product Launches and Product Expansions:
8.5 Abcam plc
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.6 Genscript Biotech Corporation
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Regional & Segmental Analysis
8.6.4 Research & Development Expenses
8.7 Miltenyi Biotech B.V. & Co. KG
8.7.1 Company Overview
8.8 Proteintech Group, Inc.
8.8.1 Company Overview
8.8.2 Recent strategies and developments:
8.8.2.1 Acquisition and Mergers:
8.9 BPS Bioscience, Inc.
8.9.1 Company Overview
8.10. RayBiotech Life, Inc.
8.10.1 Company Overview
TABLE 1 Europe Recombinant Proteins Market, 2018 - 2021, USD Million
TABLE 2 Europe Recombinant Proteins Market, 2022 - 2028, USD Million
TABLE 3 Europe Recombinant Proteins Market by Product, 2018 - 2021, USD Million
TABLE 4 Europe Recombinant Proteins Market by Product, 2022 - 2028, USD Million
TABLE 5 Europe Growth Factors & Chemokines Market by Country, 2018 - 2021, USD Million
TABLE 6 Europe Growth Factors & Chemokines Market by Country, 2022 - 2028, USD Million
TABLE 7 Europe Recombinant Metabolic Enzymes, Adhesion Molecules & Receptors Market by Country, 2018 - 2021, USD Million
TABLE 8 Europe Recombinant Metabolic Enzymes, Adhesion Molecules & Receptors Market by Country, 2022 - 2028, USD Million
TABLE 9 Europe Structural Proteins Market by Country, 2018 - 2021, USD Million
TABLE 10 Europe Structural Proteins Market by Country, 2022 - 2028, USD Million
TABLE 11 Europe Membrane Proteins Market by Country, 2018 - 2021, USD Million
TABLE 12 Europe Membrane Proteins Market by Country, 2022 - 2028, USD Million
TABLE 13 Europe Kinase Proteins & Regulatory Proteins Market by Country, 2018 - 2021, USD Million
TABLE 14 Europe Kinase Proteins & Regulatory Proteins Market by Country, 2022 - 2028, USD Million
TABLE 15 Europe Immune Response Proteins Market by Country, 2018 - 2021, USD Million
TABLE 16 Europe Immune Response Proteins Market by Country, 2022 - 2028, USD Million
TABLE 17 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 18 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 19 Europe Recombinant Proteins Market by End User, 2018 - 2021, USD Million
TABLE 20 Europe Recombinant Proteins Market by End User, 2022 - 2028, USD Million
TABLE 21 Europe Pharmaceutical & Biopharmaceutical Companies Market by Country, 2018 - 2021, USD Million
TABLE 22 Europe Pharmaceutical & Biopharmaceutical Companies Market by Country, 2022 - 2028, USD Million
TABLE 23 Europe Biotechnology Companies Market by Country, 2018 - 2021, USD Million
TABLE 24 Europe Biotechnology Companies Market by Country, 2022 - 2028, USD Million
TABLE 25 Europe Academic Research Institutes Market by Country, 2018 - 2021, USD Million
TABLE 26 Europe Academic Research Institutes Market by Country, 2022 - 2028, USD Million
TABLE 27 Europe Contract Research Organizations Market by Country, 2018 - 2021, USD Million
TABLE 28 Europe Contract Research Organizations Market by Country, 2022 - 2028, USD Million
TABLE 29 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 30 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 31 Europe Recombinant Proteins Market by Application, 2018 - 2021, USD Million
TABLE 32 Europe Recombinant Proteins Market by Application, 2022 - 2028, USD Million
TABLE 33 Europe Drug Discovery & Development Market by Country, 2018 - 2021, USD Million
TABLE 34 Europe Drug Discovery & Development Market by Country, 2022 - 2028, USD Million
TABLE 35 Europe Academic Research Studies Market by Country, 2018 - 2021, USD Million
TABLE 36 Europe Academic Research Studies Market by Country, 2022 - 2028, USD Million
TABLE 37 Europe Biopharmaceutical Production Market by Country, 2018 - 2021, USD Million
TABLE 38 Europe Biopharmaceutical Production Market by Country, 2022 - 2028, USD Million
TABLE 39 Europe Diagnostics Market by Country, 2018 - 2021, USD Million
TABLE 40 Europe Diagnostics Market by Country, 2022 - 2028, USD Million
TABLE 41 Europe Biotechnology Research Market by Country, 2018 - 2021, USD Million
TABLE 42 Europe Biotechnology Research Market by Country, 2022 - 2028, USD Million
TABLE 43 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 44 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 45 Europe Recombinant Proteins Market by Country, 2018 - 2021, USD Million
TABLE 46 Europe Recombinant Proteins Market by Country, 2022 - 2028, USD Million
TABLE 47 Germany Recombinant Proteins Market, 2018 - 2021, USD Million
TABLE 48 Germany Recombinant Proteins Market, 2022 - 2028, USD Million
TABLE 49 Germany Recombinant Proteins Market by Product, 2018 - 2021, USD Million
TABLE 50 Germany Recombinant Proteins Market by Product, 2022 - 2028, USD Million
TABLE 51 Germany Recombinant Proteins Market by End User, 2018 - 2021, USD Million
TABLE 52 Germany Recombinant Proteins Market by End User, 2022 - 2028, USD Million
TABLE 53 Germany Recombinant Proteins Market by Application, 2018 - 2021, USD Million
TABLE 54 Germany Recombinant Proteins Market by Application, 2022 - 2028, USD Million
TABLE 55 UK Recombinant Proteins Market, 2018 - 2021, USD Million
TABLE 56 UK Recombinant Proteins Market, 2022 - 2028, USD Million
TABLE 57 UK Recombinant Proteins Market by Product, 2018 - 2021, USD Million
TABLE 58 UK Recombinant Proteins Market by Product, 2022 - 2028, USD Million
TABLE 59 UK Recombinant Proteins Market by End User, 2018 - 2021, USD Million
TABLE 60 UK Recombinant Proteins Market by End User, 2022 - 2028, USD Million
TABLE 61 UK Recombinant Proteins Market by Application, 2018 - 2021, USD Million
TABLE 62 UK Recombinant Proteins Market by Application, 2022 - 2028, USD Million
TABLE 63 France Recombinant Proteins Market, 2018 - 2021, USD Million
TABLE 64 France Recombinant Proteins Market, 2022 - 2028, USD Million
TABLE 65 France Recombinant Proteins Market by Product, 2018 - 2021, USD Million
TABLE 66 France Recombinant Proteins Market by Product, 2022 - 2028, USD Million
TABLE 67 France Recombinant Proteins Market by End User, 2018 - 2021, USD Million
TABLE 68 France Recombinant Proteins Market by End User, 2022 - 2028, USD Million
TABLE 69 France Recombinant Proteins Market by Application, 2018 - 2021, USD Million
TABLE 70 France Recombinant Proteins Market by Application, 2022 - 2028, USD Million
TABLE 71 Russia Recombinant Proteins Market, 2018 - 2021, USD Million
TABLE 72 Russia Recombinant Proteins Market, 2022 - 2028, USD Million
TABLE 73 Russia Recombinant Proteins Market by Product, 2018 - 2021, USD Million
TABLE 74 Russia Recombinant Proteins Market by Product, 2022 - 2028, USD Million
TABLE 75 Russia Recombinant Proteins Market by End User, 2018 - 2021, USD Million
TABLE 76 Russia Recombinant Proteins Market by End User, 2022 - 2028, USD Million
TABLE 77 Russia Recombinant Proteins Market by Application, 2018 - 2021, USD Million
TABLE 78 Russia Recombinant Proteins Market by Application, 2022 - 2028, USD Million
TABLE 79 Spain Recombinant Proteins Market, 2018 - 2021, USD Million
TABLE 80 Spain Recombinant Proteins Market, 2022 - 2028, USD Million
TABLE 81 Spain Recombinant Proteins Market by Product, 2018 - 2021, USD Million
TABLE 82 Spain Recombinant Proteins Market by Product, 2022 - 2028, USD Million
TABLE 83 Spain Recombinant Proteins Market by End User, 2018 - 2021, USD Million
TABLE 84 Spain Recombinant Proteins Market by End User, 2022 - 2028, USD Million
TABLE 85 Spain Recombinant Proteins Market by Application, 2018 - 2021, USD Million
TABLE 86 Spain Recombinant Proteins Market by Application, 2022 - 2028, USD Million
TABLE 87 Italy Recombinant Proteins Market, 2018 - 2021, USD Million
TABLE 88 Italy Recombinant Proteins Market, 2022 - 2028, USD Million
TABLE 89 Italy Recombinant Proteins Market by Product, 2018 - 2021, USD Million
TABLE 90 Italy Recombinant Proteins Market by Product, 2022 - 2028, USD Million
TABLE 91 Italy Recombinant Proteins Market by End User, 2018 - 2021, USD Million
TABLE 92 Italy Recombinant Proteins Market by End User, 2022 - 2028, USD Million
TABLE 93 Italy Recombinant Proteins Market by Application, 2018 - 2021, USD Million
TABLE 94 Italy Recombinant Proteins Market by Application, 2022 - 2028, USD Million
TABLE 95 Rest of Europe Recombinant Proteins Market, 2018 - 2021, USD Million
TABLE 96 Rest of Europe Recombinant Proteins Market, 2022 - 2028, USD Million
TABLE 97 Rest of Europe Recombinant Proteins Market by Product, 2018 - 2021, USD Million
TABLE 98 Rest of Europe Recombinant Proteins Market by Product, 2022 - 2028, USD Million
TABLE 99 Rest of Europe Recombinant Proteins Market by End User, 2018 - 2021, USD Million
TABLE 100 Rest of Europe Recombinant Proteins Market by End User, 2022 - 2028, USD Million
TABLE 101 Rest of Europe Recombinant Proteins Market by Application, 2018 - 2021, USD Million
TABLE 102 Rest of Europe Recombinant Proteins Market by Application, 2022 - 2028, USD Million
TABLE 103 Key Information – Bio-Techne Corporation
TABLE 104 Key Information – Thermo Fisher Scientific, Inc.
TABLE 105 key Information – Merck GrouP
TABLE 106 Key Information – Bio-Rad Laboratories, Inc.
TABLE 107 key information – Abcam plc
TABLE 108 Key information – Genscript Biotech Corporation
TABLE 109 Key information – Miltenyi Biotec B.V. & Co. KG
TABLE 110 Key Information – Proteintech Group, Inc.
TABLE 111 Key Information – BPS Bioscience, Inc.
TABLE 112 Key Information – RayBiotech Life, Inc.
List of Figures
FIG 1 Methodology for the research